Growth Metrics

Incyte (INCY) EBIAT (2016 - 2025)

Incyte (INCY) has disclosed EBIAT for 16 consecutive years, with $299.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 48.74% year-over-year to $299.3 million, compared with a TTM value of $1.3 billion through Dec 2025, up 3844.96%, and an annual FY2025 reading of $1.3 billion, up 3844.96% over the prior year.
  • EBIAT was $299.3 million for Q4 2025 at Incyte, down from $424.2 million in the prior quarter.
  • Across five years, EBIAT topped out at $563.9 million in Q4 2021 and bottomed at -$444.6 million in Q2 2024.
  • Average EBIAT over 5 years is $160.3 million, with a median of $165.5 million recorded in 2022.
  • The sharpest move saw EBIAT soared 1295.65% in 2021, then tumbled 318.43% in 2024.
  • Year by year, EBIAT stood at $563.9 million in 2021, then plummeted by 94.95% to $28.5 million in 2022, then soared by 606.51% to $201.1 million in 2023, then increased by 0.07% to $201.2 million in 2024, then skyrocketed by 48.74% to $299.3 million in 2025.
  • Business Quant data shows EBIAT for INCY at $299.3 million in Q4 2025, $424.2 million in Q3 2025, and $405.0 million in Q2 2025.